Global artificial intelligence (AI) market is anticipated to grow at a significant CAGR of 38.7% during the forecast period (2024-2031). The market growth is attributed to the increasing advancements in technology such as algorithms, machine learning techniques, and natural language processing, enabling the development of sophisticated autonomous AI systems globally. The market is expanding mostly owing to increased funding and investment for AI start-ups. According to the World Economic Forum (WEF), in May 2024, in the US, a fervent gold rush in private AI investment has catalyzed transformative developments across key sectors such as autonomous vehicles, healthcare, and IT infrastructure.

The global LiDAR market is anticipated to grow at a considerable CAGR of 15% during the forecast period. The several launches by players across the globe are key factors propelling the growth of the market during the forecast period. For instance, in March 2022, Ouster, Inc. and Tacticaware, a Hexagon company that manufactures and produces the volumetric security system Accur8vision, announced the launch of their joint security solution: Ouster x Accur8vision. The solution combines Ouster’s 3D digital lidar technology with Hexagon’s industry-leading security software to target the multibillion-dollar physical security market.

The global 3D concrete printing market is anticipated to grow at a considerable CAGR of 20.9% during the forecast period (2022-2028). Efficient use of raw materials with less wastage is a major factor driving the growth of 3D concrete printing market. 3D printing is an additive manufacturing process which uses only that much material which is necessary for creating a structure. Although, 3D printing won’t be able to solve all of the construction waste problems, but when paired with other waste-reducing processes and building methods such as prefabrication and lean construction, the potential of a waste-zero building seems to be possible.

The global invasive sensors market is anticipated to grow at a considerable CAGR of 10.1% during the forecast period. Various new launches are boosting the growth of the global invasive sensors market over the forecast period. For instance, in March 2021, OMNIVISION Technologies, Inc., a leading developer of advanced digital imaging solutions, announced its new OH0TA OVMed medical image sensor—with a package size of just 0.55 mm x 0.55 mm, featuring a 1.0-micron pixel and a 1/31 optical format—smaller than the Guinness World Record held by its predecessor for the “Smallest Commercially Available Image Sensor.” This allows designers to add ultra-compact visualization to single-use and reusable endoscopes, as well as catheters and guidewires, with a small outer diameter of 1-2 mm. alternatively, this sensor’s uniquely small size gives medical device OEMs the flexibility to create a larger-diameter scope with a larger working channel.

The global CRISPR market is anticipated to grow at a considerable CAGR of 36.8 % during the forecast period (2022-2028). Several researchers showed that a gene-editing tool called CRISPR could alter the DNA of human cells like a very precise and easy-to-use pair of scissors. The various launches and development in CRISPR technology are propelling the growth of the market during the forecast. For instance, in March 2021, Scientists at UC San Francisco, UC Berkeley, and UCLA have received U.S. Food and Drug Administration approval to jointly launch an early phase, first-in-human clinical trial of a CRISPR gene correction therapy in patients with sickle cell disease using the patient’s own blood-forming stem cells. 

The global fluoroscopy system market is anticipated to grow at a considerable CAGR of 4.3% during the forecast period (2022-2028). The key factor that augments the market growth is advancements in technologies used in the medical devices and healthcare field such as rotational angiography with Computed Tomography (CT) images, usage of thallium-doped cesium iodide coupled with magnifying fluoroscopes, and integration with image intensifiers are anticipated to drive the market growth. 

The global cancer gene therapy market is anticipated to grow at a considerable CAGR of 23.1% during the forecast period. One of the key factors that are fueling the market is the growing competitiveness between the market players. With several key players in the market, companies are advancing, innovating, and launching new products to stay in the competition. For instance, in April 2022, Labcorp enhances cell and gene therapy development support through collaboration with X-cell biosciences. 

The global cardiomyopathy market is anticipated to grow at a considerable CAGR of 4.2% during the forecast period (2022-2028). The key companies operating in the industry are highly inclined towards the adoption of different growth strategies including capacity expansion, partnerships, mergers and acquisitions, geographical expansion, new product launches, and product innovation to remain competitive in the marketplace this is anticipated to hold significant growth. For instance, In April 2022, LianBio’s and Bristol-Myers Squibb partnered and developed Camzyos medicine which has been approved by U.S. Food and Drug Administration (FDA). 

The global cancer biomarker market is anticipated to grow at a considerable CAGR of 5.1% during the forecast period. The major factor contributing to the growth of the market is the rising adoption of several R&D activities by the key market players along with FDA approvals across the globe For instance, in March 2021, Roche announced that the VENTANA ALK (D5F3) CDx Assay has been approved as a companion diagnostic by the US Food and Drug Administration. This assay test is the only one approved by the FDA as a companion diagnostic for LORBRENA, and it will aid in quickly identifying patients with this cancer biomarker so that they can receive more effective treatment.

The global artificial photosynthesis market is anticipated to grow at a considerable CAGR of 12% during the forecast period (2022-2030). The major factor contributing to the market growth are technological development, and rising funding and investment activities in artificial photosynthesis are creating the future opportunity for commercialization and market growth.